MAXCYTE INC. - COMMON
3.8300
08-October-24 14:09:13
15 minutes delayed
Stocks
+0.0500
+1.32%
Today's range
3.7500 - 3.8900
ISIN
N/A
Source
NASDAQ
-
16 Sep 2024 02:00:00 By Nasdaq GlobeNewswire
-
MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference
05 Sep 2024 16:05:00 By Nasdaq GlobeNewswire
-
06 Aug 2024 16:05:01 By Nasdaq GlobeNewswire
-
MaxCyte to Report Second Quarter 2024 Financial Results on August 6, 2024
09 Jul 2024 16:05:00 By Nasdaq GlobeNewswire
-
MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference
29 May 2024 08:05:00 By Nasdaq GlobeNewswire
-
22 May 2024 08:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
07 May 2024 16:05:01 By Nasdaq GlobeNewswire
-
MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024
10 Apr 2024 08:05:00 By Nasdaq GlobeNewswire
-
02 Apr 2024 08:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
12 Mar 2024 16:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results
04 Mar 2024 16:05:00 By Nasdaq GlobeNewswire
-
09 Feb 2024 08:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
23 Jan 2024 08:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results
08 Jan 2024 16:05:00 By Nasdaq GlobeNewswire
-
MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR's TCR-T Cell Pipeline
03 Jan 2024 08:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director
02 Jan 2024 02:00:00 By Nasdaq GlobeNewswire
-
MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023
11 Dec 2023 16:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Joins the Alliance for mRNA Medicines (AMM) as a Founding Member
16 Nov 2023 08:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Reports Third Quarter 2023 Financial Results and Reiterates Full Year 2023 Revenue Guidance
08 Nov 2023 16:05:01 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >